Article(id=1329913747520467465, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329913746920681993, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2018.10.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1529337600000, receivedDateStr=2018-06-19, revisedDate=1535040000000, revisedDateStr=2018-08-24, acceptedDate=null, acceptedDateStr=null, onlineDate=1795005746010, onlineDateStr=2026-11-18, pubDate=1539100800000, pubDateStr=2018-10-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795005746010, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795005746010, creator=13701087609, updateTime=1795005746010, updator=13701087609, issue=Issue{id=1329913746920681993, tenantId=1146029695717560320, journalId=1319690329412173987, year='2018', volume='39', issue='10', pageStart='649', pageEnd='720', issueExtLink='null', onlineDate='null', pubDate='1539100800000', pubDateStr='2018-10-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795005745868, creator='13701087609', updateTime=1795056465582, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330126481231033225, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329913746920681993, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330126481231033226, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329913746920681993, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=649, endPage=654, ext={EN=ArticleExt(id=1329913747839234570, articleId=1329913747520467465, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Progress in drug therapy for hyperuricemia kidney damage, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Hyperuricemia is an independent risk factor for chronic kidney disease (CKD) and its progression. In recent years, the incidence of hyperuricemia has been increasing rapidly in China. The clinical type of hyperuricemia includes acute uric acid nephropathy, chronic uric acid nephropathy and uric acid nephrolithiasis. Proper drug treatment can reduce the level of serum uric acid, and may improve the overall prognosis of CKD. This review describes several types of hyperuricemia kidney damage and the clinical evaluation of therapeutic agents.

, authors=Yong-ping GUO1, Nian-song WANG2, *, authorsList=Yong-ping GUO, Nian-song WANG, authorCompany=null, correspAuthors=Nian-song WANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329913748166390284, articleId=1329913747520467465, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=高尿酸血症肾脏损害的药物治疗进展, columnId=1329913747923120651, journalTitle=世界临床药物, columnName=医药专论·结缔组织疾病相关性肾损害专题, runingTitle=null, highlight=null, articleAbstract=

高尿酸血症是慢性肾脏病(CKD)发生和进展的独立危险因素,近年来我国成人高尿酸血症的发病率呈快速上升趋势。临床上高尿酸血症肾损害的类型包括急性尿酸性肾病、慢性尿酸性肾病和尿酸性肾石症。适当的药物治疗可降低血尿酸水平,还可在一定程度上改善CKD患者的整体预后。本文综述高尿酸血症肾脏损害类型及治疗药物的临床评价。

, authors=郭永平1, 汪年松2, *, authorsList=郭永平, 汪年松, authorCompany=null, correspAuthors=汪年松, authorNote=

郭永平,科副主任,副主任医师,医学博士,浦东新区医学会肾脏病专委会委员,临床长期从事肾脏内科疾病的诊治工作,对各种慢性肾脏病的诊治,包括慢性肾小球肾炎、狼疮性肾炎、糖尿病肾病等的临床处理有一定经验。

, correspAuthorsNote=
汪年松,科主任,主任医师,教授,博士生导师,擅长各种急慢性肾病、各种风湿性疾病的诊治,尤其对糖尿病肾病、强直性脊柱炎、延缓慢性肾功能不全进展、各种血液净化技术的应用和各种透析并发症的防治有较深入的研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=nS3RlHwR4o4YJw5u5JBtXg==, magXml=XXcZi5wo/D5xrBZ0bBf8YA==, pdfUrl=null, pdf=+1ynY8vwryTpelSIh7Oh+A==, pdfFileSize=958397, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=KHEpPJ7aCCvHpdVZaJcYMg==, mapNumber=null, fund=null)}, authors=[Author(id=1329913748577432084, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329913748648735254, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, authorId=1329913748577432084, language=EN, stringName=Yong-ping GUO, firstName=Yong-ping, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Nephrology, Shanghai Sixth People's Hospital East Campus Affiliated to Shanghai University of Medcine & Health Sciences, Shanghai 201306, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329913748707455511, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, authorId=1329913748577432084, language=CN, stringName=郭永平, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海健康医学院附属上海市第六人民医院东院肾脏风湿科,上海 201306, bio={"content":"

郭永平,科副主任,副主任医师,医学博士,浦东新区医学会肾脏病专委会委员,临床长期从事肾脏内科疾病的诊治工作,对各种慢性肾脏病的诊治,包括慢性肾小球肾炎、狼疮性肾炎、糖尿病肾病等的临床处理有一定经验。

"}, bioImg=null, bioContent=

郭永平,科副主任,副主任医师,医学博士,浦东新区医学会肾脏病专委会委员,临床长期从事肾脏内科疾病的诊治工作,对各种慢性肾脏病的诊治,包括慢性肾小球肾炎、狼疮性肾炎、糖尿病肾病等的临床处理有一定经验。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329913748405465613, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, xref=1., ext=[AuthorCompanyExt(id=1329913748413854222, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, companyId=1329913748405465613, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Shanghai Sixth People's Hospital East Campus Affiliated to Shanghai University of Medcine & Health Sciences, Shanghai 201306), AuthorCompanyExt(id=1329913748422242831, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, companyId=1329913748405465613, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海健康医学院附属上海市第六人民医院东院肾脏风湿科,上海 201306)])]), Author(id=1329913748782952985, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329913748858450459, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, authorId=1329913748782952985, language=EN, stringName=Nian-song WANG, firstName=Nian-song, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Nephrology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329913748929753628, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, authorId=1329913748782952985, language=CN, stringName=汪年松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.上海交通大学附属第六人民医院肾脏内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329913748493546000, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, xref=2., ext=[AuthorCompanyExt(id=1329913748506128913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, companyId=1329913748493546000, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Nephrology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329913748514517522, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, companyId=1329913748493546000, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海交通大学附属第六人民医院肾脏内科,上海 200233)])])], keywords=[Keyword(id=1329913749013639709, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, language=EN, orderNo=1, keyword=hyperuricemia), Keyword(id=1329913749072359966, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, language=EN, orderNo=2, keyword=chronic kidney disease (CKD)), Keyword(id=1329913749168828959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, language=EN, orderNo=3, keyword=drug therapy), Keyword(id=1329913749252715040, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, language=CN, orderNo=1, keyword=高尿酸血症), Keyword(id=1329913749315629601, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, language=CN, orderNo=2, keyword=慢性肾脏病(CKD)), Keyword(id=1329913749420487202, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, language=CN, orderNo=3, keyword=药物治疗)], refs=[Reference(id=1329913749617619492, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=高尿酸血症相关疾病诊疗多学科共识专家组. 中国高尿酸血症相关疾病诊疗多学科专家共识[J]. 中华内科杂志, 2017, 56(3): 235-248., articleTitle=null, refAbstract=null), Reference(id=1329913749684728357, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Vargas-Santos AB, Neogi T. Management of gout and hyperuricemia in CKD[J]. Am J Kidney Dis, 2017, 70(3): 422-439., articleTitle=null, refAbstract=null), Reference(id=1329913749747642918, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the national health and nutrition examination survey 2007-2008[J]. Arthritis Rheum, 2011, 63(10): 3136-3141., articleTitle=null, refAbstract=null), Reference(id=1329913749844111911, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu H, Zhang XM, Wang YL, et al. Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling[J]. J Nephrol, 2014, 27(6): 653-658., articleTitle=null, refAbstract=null), Reference(id=1329913749911220776, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu R, Han C, Wu D, et al. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis[J]. Biomed Res Int, 2015, 2015: 762820-762820., articleTitle=null, refAbstract=null), Reference(id=1329913749974135337, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Rieselbach RE, Steele TH. Influence of the kidney upon urate homeostasis in health and disease[J]. Am J Med, 1974, 56(5): 665-675., articleTitle=null, refAbstract=null), Reference(id=1329913750058021418, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Li L, Yang C, Zhao Y, et al. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease? A systematic review and meta-analysis based on observational cohort studies[J]. Bio Med Central Nephrol, 2014, 15(1): 122-122., articleTitle=null, refAbstract=null), Reference(id=1329913750146101804, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Chang HY, Tung CW, Lee PH, et al. Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population[J]. Am J Med Sci, 2010, 339(6): 509-515., articleTitle=null, refAbstract=null), Reference(id=1329913750225793581, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Obermayr RP, Temml C, Gutjahr G, et al. Elevated uric acid increases the risk for kidney disease[J]. J Am Soc Nephrol, 2008, 19(12): 2407-2413., articleTitle=null, refAbstract=null), Reference(id=1329913750301291054, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Chonchol M, Shlipak MG, Katz R, et al. Relationship of uric acid with progression of kidney disease[J]. Am J Kidney Dis, 2007, 50(2): 239-247., articleTitle=null, refAbstract=null), Reference(id=1329913750355817007, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Iseki K, Ikemiya Y, Inoue T, et al. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort[J]. Am J Kidney Dis, 2004, 44(4): 642-650., articleTitle=null, refAbstract=null), Reference(id=1329913750406148656, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=中国医师协会肾脏内科医师分会. 中国肾脏疾病高尿酸血症诊治的实践指南(2017版)[J]. 中华医学杂志, 2017, 97(25): 1927-1936., articleTitle=null, refAbstract=null), Reference(id=1329913750464868913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会风湿病学分会. 2016中国痛风诊疗指南[J]. 浙江医学, 2017, 39(21): 1823-1832., articleTitle=null, refAbstract=null), Reference(id=1329913750544560690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Stamp LK, O'Donnell JL, Zhang M, et al. Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment[J]. Arthritis Rheum, 2011, 63(2): 412-421., articleTitle=null, refAbstract=null), Reference(id=1329913750607475251, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Jalalzadeh M, Nurcheshmeh Z, Mohammadi R, et al. The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia[J]. J Res Med Sci, 2012, 17(11): 1039-1046., articleTitle=null, refAbstract=null), Reference(id=1329913750678778420, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Kim Y, Shin S, Kim K, et al. Effect of urate lowering therapy on renal disease progression in hyperuricemia patients with chronic kidney disease[J]. J Rheumatol, 2015, 42(11): 2143-2148., articleTitle=null, refAbstract=null), Reference(id=1329913750750081589, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Siren S, Sebnem K, Berna A, et al. Allopurinol reduces cardiovascular risks and improves renal function in pre-dialysis chronic kidney disease patients with hyperuricemia[J]. Saudi J Kidney Dis Transpl, 2014, 25(2): 316-320., articleTitle=null, refAbstract=null), Reference(id=1329913750833967670, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Ghane Sharbaf F, Assadi F. Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease[J]. Pediatr Nephrol, 2018, 33(8): 1405-1409., articleTitle=null, refAbstract=null), Reference(id=1329913750917853751, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Chou HW, Chiu HT, Tsai CW, et al. Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception cohort study[J]. Nephrol Dial Transplant, 2017, doi: 10.1093/ndt/gfx313., articleTitle=null, refAbstract=null), Reference(id=1329913750989156920, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Krishnamurthy A, Lazaro D, Stefanov DG, et al. The Effect of allopurinol on renal function[J]. J Clin Rheumatol, 2017, 23(1): 1-5., articleTitle=null, refAbstract=null), Reference(id=1329913751064654393, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Nikolaos P, Samad K, Felix SS, et al. Effects of treatment of asymptomatic hyperuricemia on graft survival and mortality in kidney transplant recipients[J]. Ann Transplant, 2016, 21(1): 350-359., articleTitle=null, refAbstract=null), Reference(id=1329913751144346170, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Lim DH, Oh JS, Ahn SM, et al. Febuxostat in hyperuricemia patients with advanced CKD[J]. Am J Kidney Dis, 2016, 68(5): 819-821., articleTitle=null, refAbstract=null), Reference(id=1329913751207260731, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Frassetto LA, Gibson S. Febuxostat and increased dialysis as a treatment for severe tophaceous gout in a hemodialysis patient[J]. Case Rep Nephrol, 2016, doi: 10.1155/2016/9106935., articleTitle=null, refAbstract=null), Reference(id=1329913751299535420, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Sofue T, Inui M, Hara T, et al. Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients[J]. Drug Des Devel Ther, 2014, 8(1): 245-253., articleTitle=null, refAbstract=null), Reference(id=1329913751366644285, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Xiang XZ, Yun LT, Kai XH, et al. Efficacy of febuxostat in hyperuricemic patients with mild-to-moderate chronic kidney disease: a meta-analysis of randomized clinical trials[J]. Medicine, 2018, 97(13): e0161-e0161., articleTitle=null, refAbstract=null), Reference(id=1329913751416975934, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Yuki T, Toshio M, Takahito M, et al. Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease[J]. Clin Rheumatol, 2014, 33(11): 1643-1648., articleTitle=null, refAbstract=null), Reference(id=1329913751471501887, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Kim S, Kim HJ, Ahn HS, et al. Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: a systematic review and meta-analysis[J]. Kidney Res Clin Pract, 2017, 36(3): 274-281., articleTitle=null, refAbstract=null), Reference(id=1329913751546999360, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Horino T, Hatakeyama Y, Ichii O, et al. Effects of topiroxostat in hyperuricemic patients with chronic kidney disease[J]. Clin Exp Nephrol, 2018, 22(2): 337-345., articleTitle=null, refAbstract=null), Reference(id=1329913751639274049, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Mitsuboshi S, Yamada H, Nagai K, et al. Comparison of clinical advantage between topiroxostat and febuxostat in hemodialysis patients[J]. Biol Pharm Bull, 2017, 40(9): 1463-1467., articleTitle=null, refAbstract=null), Reference(id=1329913751702188610, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Fujimori S, Ooyama K, Ooyama H, et al. Efficacy of benzbromarone in hyperuricemic patients associated with chronic kidney disease[J]. Nucleotides Nucleic Acids, 2011, 30(12): 1035-1038., articleTitle=null, refAbstract=null), Reference(id=1329913751760908867, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Nicola D, Graeme J, Robert T, et al. Lesinurad, a selective uric acid reabsorption inhibitor, in combination with febuxostat in patients with tophaceous gout[J]. Arthritis Rheumatol, 2017, 69(9): 1903-1913., articleTitle=null, refAbstract=null), Reference(id=1329913751832212036, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Roy F, Peter W, Jeffrey NM, et al. Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase Ⅱ a, open-label study[J]. RMD Open, 2018, 4(1): e000584-e000584., articleTitle=null, refAbstract=null), Reference(id=1329913751895126597, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Bleyer AJ, Wright D, Alcorn H. Pharmacokinetics and pharmacodynamics of pegloticase in patients with end-stage renal failure receiving hemodialysis[J]. Clin Nephrol, 2015, 83(5): 286-292., articleTitle=null, refAbstract=null), Reference(id=1329913751949652550, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Saito J, Matsuzawa Y, Ito H, et al. The alkalizer citrate reduces serum uric acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinol[J]. Endocr Res, 2010, 35(4): 145-154., articleTitle=null, refAbstract=null), Reference(id=1329913752012567111, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Guo Y, Jiang Q, Gui D, et al. Chinese herbal formulas Si-Wu-Tang and Er-Miao-San synergistically ameliorated hyperuricemia and renal impairment in rats induced by adenine and potassium oxonate[J]. Cell Physiol Biochem, 2015, 37(4): 1491-1502., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329913749529539107, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, awardId=HMSF-17-22-016, language=CN, fundingSource=上海健康医学院种子基金项目(HMSF-17-22-016), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329913748405465613, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, xref=1., ext=[AuthorCompanyExt(id=1329913748413854222, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, companyId=1329913748405465613, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Shanghai Sixth People's Hospital East Campus Affiliated to Shanghai University of Medcine & Health Sciences, Shanghai 201306), AuthorCompanyExt(id=1329913748422242831, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, companyId=1329913748405465613, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海健康医学院附属上海市第六人民医院东院肾脏风湿科,上海 201306)]), AuthorCompany(id=1329913748493546000, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, xref=2., ext=[AuthorCompanyExt(id=1329913748506128913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, companyId=1329913748493546000, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Nephrology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329913748514517522, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, companyId=1329913748493546000, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海交通大学附属第六人民医院肾脏内科,上海 200233)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2018.10.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2018.10.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2018.10.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2018.10.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1539100800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
高尿酸血症肾脏损害的药物治疗进展
郭永平 1 , 汪年松 2, *
世界临床药物 | 医药专论·结缔组织疾病相关性肾损害专题 2018,39(10): 649-654
收起
收藏切换
世界临床药物 |医药专论·结缔组织疾病相关性肾损害专题 2018 , 39 (10) : 649 -654
高尿酸血症肾脏损害的药物治疗进展
全屏
[Author(id=1329913748577432084, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329913748648735254, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, authorId=1329913748577432084, language=EN, stringName=Yong-ping GUO, firstName=Yong-ping, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Nephrology, Shanghai Sixth People's Hospital East Campus Affiliated to Shanghai University of Medcine & Health Sciences, Shanghai 201306, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329913748707455511, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, authorId=1329913748577432084, language=CN, stringName=郭永平, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海健康医学院附属上海市第六人民医院东院肾脏风湿科,上海 201306, bio={"content":"

郭永平,科副主任,副主任医师,医学博士,浦东新区医学会肾脏病专委会委员,临床长期从事肾脏内科疾病的诊治工作,对各种慢性肾脏病的诊治,包括慢性肾小球肾炎、狼疮性肾炎、糖尿病肾病等的临床处理有一定经验。

"}, bioImg=null, bioContent=

郭永平,科副主任,副主任医师,医学博士,浦东新区医学会肾脏病专委会委员,临床长期从事肾脏内科疾病的诊治工作,对各种慢性肾脏病的诊治,包括慢性肾小球肾炎、狼疮性肾炎、糖尿病肾病等的临床处理有一定经验。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329913748405465613, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, xref=1., ext=[AuthorCompanyExt(id=1329913748413854222, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, companyId=1329913748405465613, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Shanghai Sixth People's Hospital East Campus Affiliated to Shanghai University of Medcine & Health Sciences, Shanghai 201306), AuthorCompanyExt(id=1329913748422242831, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, companyId=1329913748405465613, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海健康医学院附属上海市第六人民医院东院肾脏风湿科,上海 201306)])]), Author(id=1329913748782952985, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329913748858450459, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, authorId=1329913748782952985, language=EN, stringName=Nian-song WANG, firstName=Nian-song, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Nephrology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329913748929753628, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, authorId=1329913748782952985, language=CN, stringName=汪年松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.上海交通大学附属第六人民医院肾脏内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329913748493546000, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, xref=2., ext=[AuthorCompanyExt(id=1329913748506128913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, companyId=1329913748493546000, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Nephrology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329913748514517522, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913747520467465, companyId=1329913748493546000, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海交通大学附属第六人民医院肾脏内科,上海 200233)])])]
郭永平1, 汪年松2, *
作者信息
  • 1.上海健康医学院附属上海市第六人民医院东院肾脏风湿科,上海 201306
  • 2.上海交通大学附属第六人民医院肾脏内科,上海 200233
通讯作者:
汪年松,科主任,主任医师,教授,博士生导师,擅长各种急慢性肾病、各种风湿性疾病的诊治,尤其对糖尿病肾病、强直性脊柱炎、延缓慢性肾功能不全进展、各种血液净化技术的应用和各种透析并发症的防治有较深入的研究。
作者简介:

郭永平,科副主任,副主任医师,医学博士,浦东新区医学会肾脏病专委会委员,临床长期从事肾脏内科疾病的诊治工作,对各种慢性肾脏病的诊治,包括慢性肾小球肾炎、狼疮性肾炎、糖尿病肾病等的临床处理有一定经验。

Progress in drug therapy for hyperuricemia kidney damage
Yong-ping GUO1, Nian-song WANG2, *
Affiliations
  • 1.Department of Nephrology, Shanghai Sixth People's Hospital East Campus Affiliated to Shanghai University of Medcine & Health Sciences, Shanghai 201306
  • 2.Department of Nephrology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233, China
出版时间: 2018-10-10 doi: 10.13683/j.wph.2018.10.001
文章导航
收藏切换

高尿酸血症是慢性肾脏病(CKD)发生和进展的独立危险因素,近年来我国成人高尿酸血症的发病率呈快速上升趋势。临床上高尿酸血症肾损害的类型包括急性尿酸性肾病、慢性尿酸性肾病和尿酸性肾石症。适当的药物治疗可降低血尿酸水平,还可在一定程度上改善CKD患者的整体预后。本文综述高尿酸血症肾脏损害类型及治疗药物的临床评价。

高尿酸血症  /  慢性肾脏病(CKD)  /  药物治疗

Hyperuricemia is an independent risk factor for chronic kidney disease (CKD) and its progression. In recent years, the incidence of hyperuricemia has been increasing rapidly in China. The clinical type of hyperuricemia includes acute uric acid nephropathy, chronic uric acid nephropathy and uric acid nephrolithiasis. Proper drug treatment can reduce the level of serum uric acid, and may improve the overall prognosis of CKD. This review describes several types of hyperuricemia kidney damage and the clinical evaluation of therapeutic agents.

hyperuricemia  /  chronic kidney disease (CKD)  /  drug therapy
郭永平, 汪年松. 高尿酸血症肾脏损害的药物治疗进展. 世界临床药物, 2018 , 39 (10) : 649 -654 . DOI: 10.13683/j.wph.2018.10.001
Yong-ping GUO, Nian-song WANG. Progress in drug therapy for hyperuricemia kidney damage[J]. World Clinical Drug, 2018 , 39 (10) : 649 -654 . DOI: 10.13683/j.wph.2018.10.001
  • 上海健康医学院种子基金项目(HMSF-17-22-016)
参考文献 引证文献
排序方式:
[1]
高尿酸血症相关疾病诊疗多学科共识专家组. 中国高尿酸血症相关疾病诊疗多学科专家共识[J]. 中华内科杂志, 2017, 56(3): 235-248.
[2]
Vargas-Santos AB, Neogi T. Management of gout and hyperuricemia in CKD[J]. Am J Kidney Dis, 2017, 70(3): 422-439.
[3]
Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the national health and nutrition examination survey 2007-2008[J]. Arthritis Rheum, 2011, 63(10): 3136-3141.
[4]
Liu H, Zhang XM, Wang YL, et al. Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling[J]. J Nephrol, 2014, 27(6): 653-658.
[5]
Liu R, Han C, Wu D, et al. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis[J]. Biomed Res Int, 2015, 2015: 762820-762820.
[6]
Rieselbach RE, Steele TH. Influence of the kidney upon urate homeostasis in health and disease[J]. Am J Med, 1974, 56(5): 665-675.
[7]
Li L, Yang C, Zhao Y, et al. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease? A systematic review and meta-analysis based on observational cohort studies[J]. Bio Med Central Nephrol, 2014, 15(1): 122-122.
[8]
Chang HY, Tung CW, Lee PH, et al. Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population[J]. Am J Med Sci, 2010, 339(6): 509-515.
[9]
Obermayr RP, Temml C, Gutjahr G, et al. Elevated uric acid increases the risk for kidney disease[J]. J Am Soc Nephrol, 2008, 19(12): 2407-2413.
[10]
Chonchol M, Shlipak MG, Katz R, et al. Relationship of uric acid with progression of kidney disease[J]. Am J Kidney Dis, 2007, 50(2): 239-247.
[11]
Iseki K, Ikemiya Y, Inoue T, et al. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort[J]. Am J Kidney Dis, 2004, 44(4): 642-650.
[12]
中国医师协会肾脏内科医师分会. 中国肾脏疾病高尿酸血症诊治的实践指南(2017版)[J]. 中华医学杂志, 2017, 97(25): 1927-1936.
[13]
中华医学会风湿病学分会. 2016中国痛风诊疗指南[J]. 浙江医学, 2017, 39(21): 1823-1832.
[14]
Stamp LK, O'Donnell JL, Zhang M, et al. Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment[J]. Arthritis Rheum, 2011, 63(2): 412-421.
[15]
Jalalzadeh M, Nurcheshmeh Z, Mohammadi R, et al. The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia[J]. J Res Med Sci, 2012, 17(11): 1039-1046.
[16]
Kim Y, Shin S, Kim K, et al. Effect of urate lowering therapy on renal disease progression in hyperuricemia patients with chronic kidney disease[J]. J Rheumatol, 2015, 42(11): 2143-2148.
[17]
Siren S, Sebnem K, Berna A, et al. Allopurinol reduces cardiovascular risks and improves renal function in pre-dialysis chronic kidney disease patients with hyperuricemia[J]. Saudi J Kidney Dis Transpl, 2014, 25(2): 316-320.
[18]
Ghane Sharbaf F, Assadi F. Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease[J]. Pediatr Nephrol, 2018, 33(8): 1405-1409.
[19]
Chou HW, Chiu HT, Tsai CW, et al. Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception cohort study[J]. Nephrol Dial Transplant, 2017, doi: 10.1093/ndt/gfx313.
[20]
Krishnamurthy A, Lazaro D, Stefanov DG, et al. The Effect of allopurinol on renal function[J]. J Clin Rheumatol, 2017, 23(1): 1-5.
[21]
Nikolaos P, Samad K, Felix SS, et al. Effects of treatment of asymptomatic hyperuricemia on graft survival and mortality in kidney transplant recipients[J]. Ann Transplant, 2016, 21(1): 350-359.
[22]
Lim DH, Oh JS, Ahn SM, et al. Febuxostat in hyperuricemia patients with advanced CKD[J]. Am J Kidney Dis, 2016, 68(5): 819-821.
[23]
Frassetto LA, Gibson S. Febuxostat and increased dialysis as a treatment for severe tophaceous gout in a hemodialysis patient[J]. Case Rep Nephrol, 2016, doi: 10.1155/2016/9106935.
[24]
Sofue T, Inui M, Hara T, et al. Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients[J]. Drug Des Devel Ther, 2014, 8(1): 245-253.
[25]
Xiang XZ, Yun LT, Kai XH, et al. Efficacy of febuxostat in hyperuricemic patients with mild-to-moderate chronic kidney disease: a meta-analysis of randomized clinical trials[J]. Medicine, 2018, 97(13): e0161-e0161.
[26]
Yuki T, Toshio M, Takahito M, et al. Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease[J]. Clin Rheumatol, 2014, 33(11): 1643-1648.
[27]
Kim S, Kim HJ, Ahn HS, et al. Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: a systematic review and meta-analysis[J]. Kidney Res Clin Pract, 2017, 36(3): 274-281.
[28]
Horino T, Hatakeyama Y, Ichii O, et al. Effects of topiroxostat in hyperuricemic patients with chronic kidney disease[J]. Clin Exp Nephrol, 2018, 22(2): 337-345.
[29]
Mitsuboshi S, Yamada H, Nagai K, et al. Comparison of clinical advantage between topiroxostat and febuxostat in hemodialysis patients[J]. Biol Pharm Bull, 2017, 40(9): 1463-1467.
[30]
Fujimori S, Ooyama K, Ooyama H, et al. Efficacy of benzbromarone in hyperuricemic patients associated with chronic kidney disease[J]. Nucleotides Nucleic Acids, 2011, 30(12): 1035-1038.
[31]
Nicola D, Graeme J, Robert T, et al. Lesinurad, a selective uric acid reabsorption inhibitor, in combination with febuxostat in patients with tophaceous gout[J]. Arthritis Rheumatol, 2017, 69(9): 1903-1913.
[32]
Roy F, Peter W, Jeffrey NM, et al. Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase Ⅱ a, open-label study[J]. RMD Open, 2018, 4(1): e000584-e000584.
[33]
Bleyer AJ, Wright D, Alcorn H. Pharmacokinetics and pharmacodynamics of pegloticase in patients with end-stage renal failure receiving hemodialysis[J]. Clin Nephrol, 2015, 83(5): 286-292.
[34]
Saito J, Matsuzawa Y, Ito H, et al. The alkalizer citrate reduces serum uric acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinol[J]. Endocr Res, 2010, 35(4): 145-154.
[35]
Guo Y, Jiang Q, Gui D, et al. Chinese herbal formulas Si-Wu-Tang and Er-Miao-San synergistically ameliorated hyperuricemia and renal impairment in rats induced by adenine and potassium oxonate[J]. Cell Physiol Biochem, 2015, 37(4): 1491-1502.
2018年第39卷第10期
17
6
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2018.10.001
  • 接收时间:2018-06-19
  • 首发时间:2026-11-18
  • 出版时间:2018-10-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2018-06-19
  • 修回日期:2018-08-24
基金
上海健康医学院种子基金项目(HMSF-17-22-016)
作者信息
    1.上海健康医学院附属上海市第六人民医院东院肾脏风湿科,上海 201306
    2.上海交通大学附属第六人民医院肾脏内科,上海 200233

通讯作者:

汪年松,科主任,主任医师,教授,博士生导师,擅长各种急慢性肾病、各种风湿性疾病的诊治,尤其对糖尿病肾病、强直性脊柱炎、延缓慢性肾功能不全进展、各种血液净化技术的应用和各种透析并发症的防治有较深入的研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2018.10.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏